News

News Archive

Scripps Florida Scientists Develop Novel Platform for Treatment of Breast, Pancreatic Cancer Scripps Florida Scientists Develop Novel Platform for Treatment of Breast, Pancreatic Cancer

Scripps Florida Scientists Develop Novel Platform for Treatment of Breast, Pancreatic Cancer

TSRI Scientists Discover Possible New Target for Treating Brain Inflammation TSRI Scientists Discover Possible New Target for Treating Brain Inflammation

A team led by scientists at The Scripps Research Institute (TSRI) has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.

Revamped Drug May Overcome Resistance in Brain Tumours Revamped Drug May Overcome Resistance in Brain Tumours

CANCER RESEARCH UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults, according to research published in Molecular Cancer Therapeutics today (Wednesday).

MedCity chief to lead UK biotech Immunocore MedCity chief to lead UK biotech Immunocore

MedCity Executive Chair Dr Eliot Forster has been announced as the new chief executive officer of Immunocore, a leading Oxford-based biotech company focused on the discovery and development of novel cancer therapies.